🔎 Trials Near Me

Utama › Kanser Payudara › California › Sacramento

Kajian klinikal Kanser Payudara di Sacramento, CA

20 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Sacramento (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Mengambil pesertaFasa 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Mengambil pesertaFasa 3
  • Sutter Inst Medical Research, Sacramento
  • School Of Medicine, Sacramento
Umur 18 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Mengambil peserta
  • Kaiser Permanente-South Sacramento, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of California Davis, Sacramento
Umur 30 hingga 74 · Wanita · Dikemas kini 21 Sep 2026 · NCT02620852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Mengambil pesertaFasa 3
  • University Of California Davis Health System, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07173751

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Mengambil pesertaKajian pemerhatian
  • UC Davis, Sacramento
Umur 18 hingga 94 · Wanita · Dikemas kini 17 Sep 2026 · NCT07505797

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Mengambil pesertaFasa 3
  • Dignity Health dba Health Research Institute, Sacramento
  • Sutter Institute for Medical Research, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mengambil pesertaFasa 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • dan 5 lagi
Umur 18 hingga 60 · Wanita · Dikemas kini 2 Sep 2026 · NCT05879926

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of California, Davis, Sacramento
Umur 25 ke atas · Wanita · Dikemas kini 1 Sep 2026 · NCT03729115

E-Mindfulness Approaches for Living After Breast Cancer

Mengambil pesertaFasa 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Umur 18 hingga 50 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06748222

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Mengambil peserta
  • University of California, Davis, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06103669

UHFUS Characterization of Normal Lymphatic Anatomy

Mengambil peserta
  • University of California Davis Health, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jul 2026 · NCT07677839

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Mengambil pesertaFasa 2
  • University of California - Davis, Comprehensive Cancer Center, Davis · 14 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Mengambil pesertaFasa 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • dan 4 lagi
Umur 50 hingga 70 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT04852887

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Apr 2026 · NCT05785741

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Mengambil pesertaFasa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mac 2026 · NCT06268665

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Mengambil pesertaFasa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

Kajian Kanser Payudara di bandar lain

Kajian lain di Sacramento

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.